

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.56094372 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.56094372 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.30463569 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.85979838 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.69718617 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.62625408 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.62625408 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.62625408 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.62625408 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.62625408 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 5.62625408 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.57698833 |
| 13 | synaptic vesicle maturation (GO:0016188) | 5.47490709 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.37964442 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 5.33360880 |
| 16 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.23733408 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.08744090 |
| 18 | locomotory exploration behavior (GO:0035641) | 5.06632420 |
| 19 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.99913059 |
| 20 | detection of other organism (GO:0098543) | 4.91240101 |
| 21 | detection of bacterium (GO:0016045) | 4.81606219 |
| 22 | vocalization behavior (GO:0071625) | 4.73462348 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.72027339 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 4.60310513 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.58337414 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.56046816 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 4.50628133 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 4.47963466 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.47659827 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.45964006 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.38854774 |
| 32 | exploration behavior (GO:0035640) | 4.33996005 |
| 33 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 4.33294534 |
| 34 | response to interleukin-15 (GO:0070672) | 4.31027220 |
| 35 | response to peptidoglycan (GO:0032494) | 4.26982002 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.26691878 |
| 37 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.25418943 |
| 38 | protein localization to synapse (GO:0035418) | 4.24664239 |
| 39 | glutamate secretion (GO:0014047) | 4.18453595 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16451517 |
| 41 | neutrophil activation (GO:0042119) | 4.15047514 |
| 42 | neuronal action potential propagation (GO:0019227) | 4.14209720 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.13432830 |
| 44 | detection of external biotic stimulus (GO:0098581) | 4.12221927 |
| 45 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.10856796 |
| 46 | cellular extravasation (GO:0045123) | 4.06626925 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 4.06020958 |
| 48 | respiratory burst (GO:0045730) | 3.96145252 |
| 49 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.95437723 |
| 50 | dendritic spine morphogenesis (GO:0060997) | 3.88292321 |
| 51 | regulation of synaptic vesicle transport (GO:1902803) | 3.88166375 |
| 52 | dendritic spine organization (GO:0097061) | 3.85398983 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 3.84359449 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.83255297 |
| 55 | response to host immune response (GO:0052572) | 3.80882091 |
| 56 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.80882091 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.80689629 |
| 58 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.80369348 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 3.79764028 |
| 60 | granulocyte activation (GO:0036230) | 3.78354644 |
| 61 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.76215097 |
| 62 | positive regulation of membrane potential (GO:0045838) | 3.76150232 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.75116083 |
| 64 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.73571562 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 3.69967872 |
| 66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.67472785 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.65106581 |
| 68 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.64874358 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 3.63653213 |
| 70 | synaptic transmission, glutamatergic (GO:0035249) | 3.62037729 |
| 71 | layer formation in cerebral cortex (GO:0021819) | 3.62033226 |
| 72 | long-term memory (GO:0007616) | 3.61378547 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59971981 |
| 74 | detection of biotic stimulus (GO:0009595) | 3.56725432 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.54274949 |
| 76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.53684079 |
| 77 | response to host (GO:0075136) | 3.53684079 |
| 78 | response to host defenses (GO:0052200) | 3.53684079 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 3.51441113 |
| 80 | microglial cell activation (GO:0001774) | 3.51302459 |
| 81 | tolerance induction (GO:0002507) | 3.46893595 |
| 82 | regulation of synaptic plasticity (GO:0048167) | 3.45058073 |
| 83 | glutamate receptor signaling pathway (GO:0007215) | 3.43963017 |
| 84 | regulation of postsynaptic membrane potential (GO:0060078) | 3.43437620 |
| 85 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.41490560 |
| 86 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.40927499 |
| 87 | cellular response to type I interferon (GO:0071357) | 3.39888642 |
| 88 | type I interferon signaling pathway (GO:0060337) | 3.39888642 |
| 89 | positive regulation of vesicle fusion (GO:0031340) | 3.38664838 |
| 90 | response to type I interferon (GO:0034340) | 3.37352389 |
| 91 | neutrophil mediated immunity (GO:0002446) | 3.36090978 |
| 92 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.35630219 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.34782782 |
| 94 | regulation of T cell tolerance induction (GO:0002664) | 3.34394197 |
| 95 | B cell receptor signaling pathway (GO:0050853) | 3.34276520 |
| 96 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34241678 |
| 97 | neuron cell-cell adhesion (GO:0007158) | 3.33925571 |
| 98 | positive regulation of synapse maturation (GO:0090129) | 3.33214584 |
| 99 | positive regulation of neurotransmitter transport (GO:0051590) | 3.32259167 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.31773271 |
| 101 | macrophage activation (GO:0042116) | 3.31566102 |
| 102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30948782 |
| 103 | negative thymic T cell selection (GO:0045060) | 3.29020339 |
| 104 | postsynaptic membrane organization (GO:0001941) | 3.28971517 |
| 105 | germinal center formation (GO:0002467) | 3.28111224 |
| 106 | neuron-neuron synaptic transmission (GO:0007270) | 3.27768488 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 3.25155704 |
| 108 | leukocyte degranulation (GO:0043299) | 3.25019504 |
| 109 | regulation of B cell differentiation (GO:0045577) | 3.24696015 |
| 110 | regulation of vesicle fusion (GO:0031338) | 3.23310847 |
| 111 | response to muramyl dipeptide (GO:0032495) | 3.22394318 |
| 112 | neurotransmitter secretion (GO:0007269) | 3.21640710 |
| 113 | negative T cell selection (GO:0043383) | 3.20579143 |
| 114 | positive thymic T cell selection (GO:0045059) | 3.20303310 |
| 115 | positive regulation of B cell differentiation (GO:0045579) | 3.17904609 |
| 116 | positive regulation of mast cell activation (GO:0033005) | 3.14250324 |
| 117 | regulation of tolerance induction (GO:0002643) | 3.14079951 |
| 118 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13163946 |
| 119 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.11894271 |
| 120 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.11894271 |
| 121 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.10466513 |
| 122 | long-term synaptic potentiation (GO:0060291) | 3.07804656 |
| 123 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.07793377 |
| 124 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.07793377 |
| 125 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06646839 |
| 126 | neuronal ion channel clustering (GO:0045161) | 3.04759797 |
| 127 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.04494465 |
| 128 | defense response to protozoan (GO:0042832) | 3.02723116 |
| 129 | oxygen transport (GO:0015671) | 3.02302855 |
| 130 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.02284679 |
| 131 | regulation of mast cell activation (GO:0033003) | 3.00855161 |
| 132 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.99465678 |
| 133 | behavioral defense response (GO:0002209) | 2.99132481 |
| 134 | behavioral fear response (GO:0001662) | 2.99132481 |
| 135 | regulation of dendritic spine development (GO:0060998) | 2.97824063 |
| 136 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.95388261 |
| 137 | positive regulation of dendritic spine development (GO:0060999) | 2.95007367 |
| 138 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93822313 |
| 139 | auditory behavior (GO:0031223) | 2.93286593 |
| 140 | negative regulation of interleukin-6 production (GO:0032715) | 2.92433447 |
| 141 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.92409010 |
| 142 | negative regulation of innate immune response (GO:0045824) | 2.91965486 |
| 143 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.90914264 |
| 144 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90897846 |
| 145 | B cell mediated immunity (GO:0019724) | 2.90852505 |
| 146 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90083180 |
| 147 | presynaptic membrane organization (GO:0097090) | 2.88883478 |
| 148 | regulation of platelet aggregation (GO:0090330) | 2.88339059 |
| 149 | T cell selection (GO:0045058) | 2.88136052 |
| 150 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87671937 |
| 151 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87589266 |
| 152 | negative regulation of type 2 immune response (GO:0002829) | 2.87455350 |
| 153 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87152567 |
| 154 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87113004 |
| 155 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.86949652 |
| 156 | activation of protein kinase A activity (GO:0034199) | 2.83970789 |
| 157 | cellular potassium ion homeostasis (GO:0030007) | 2.81286200 |
| 158 | learning (GO:0007612) | 2.80560379 |
| 159 | leukocyte aggregation (GO:0070486) | 2.79906759 |
| 160 | visual learning (GO:0008542) | 2.79643320 |
| 161 | dopamine receptor signaling pathway (GO:0007212) | 2.79340619 |
| 162 | regulation of neurotransmitter secretion (GO:0046928) | 2.77644444 |
| 163 | neuron recognition (GO:0008038) | 2.77503034 |
| 164 | sodium ion export (GO:0071436) | 2.76017918 |
| 165 | neuromuscular process controlling balance (GO:0050885) | 2.72837168 |
| 166 | innervation (GO:0060384) | 2.71088350 |
| 167 | membrane depolarization (GO:0051899) | 2.70962207 |
| 168 | synaptic vesicle endocytosis (GO:0048488) | 2.70902012 |
| 169 | axonal fasciculation (GO:0007413) | 2.70667943 |
| 170 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.70252620 |
| 171 | response to auditory stimulus (GO:0010996) | 2.70102608 |
| 172 | positive regulation of synaptic transmission (GO:0050806) | 2.69718476 |
| 173 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.69163619 |
| 174 | fear response (GO:0042596) | 2.67745962 |
| 175 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.66105483 |
| 176 | signal complex assembly (GO:0007172) | 2.65789315 |
| 177 | barbed-end actin filament capping (GO:0051016) | 2.65538423 |
| 178 | response to histamine (GO:0034776) | 2.64825974 |
| 179 | presynaptic membrane assembly (GO:0097105) | 2.64759629 |
| 180 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.64707884 |
| 181 | cell communication by electrical coupling (GO:0010644) | 2.63452494 |
| 182 | prepulse inhibition (GO:0060134) | 2.61022952 |
| 183 | regulation of neurotransmitter transport (GO:0051588) | 2.60888140 |
| 184 | response to amphetamine (GO:0001975) | 2.60412374 |
| 185 | regulation of female receptivity (GO:0045924) | 2.60049180 |
| 186 | regulation of synapse maturation (GO:0090128) | 2.59978619 |
| 187 | regulation of synaptic transmission (GO:0050804) | 2.59216674 |
| 188 | chemosensory behavior (GO:0007635) | 2.58804483 |
| 189 | visual behavior (GO:0007632) | 2.55544892 |
| 190 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.55362267 |
| 191 | associative learning (GO:0008306) | 2.54906897 |
| 192 | membrane hyperpolarization (GO:0060081) | 2.54844082 |
| 193 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.53205543 |
| 194 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.51807752 |
| 195 | negative regulation of dendrite development (GO:2000171) | 2.49981689 |
| 196 | regulation of ARF protein signal transduction (GO:0032012) | 2.48995959 |
| 197 | mechanosensory behavior (GO:0007638) | 2.48387449 |
| 198 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.47627899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.58957523 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.18110095 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.24106420 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.08337297 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.94814122 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92122435 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.90606804 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.87952663 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.83459141 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.83254111 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81277117 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79846962 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79846962 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.77703429 |
| 15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70501068 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58314664 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.54374562 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53275231 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.51868218 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50738069 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.50612039 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50549056 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.47459788 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45822973 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.44955163 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44809504 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42590788 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37958109 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.36650005 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34584346 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.33731408 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.31803641 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.30591287 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.26531424 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.25536641 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.20437070 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.17504862 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.15224200 |
| 39 | MYB_26560356_Chip-Seq_TH2_Human | 2.13850030 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.12663171 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.10335625 |
| 42 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.10237081 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.10057654 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09232705 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08462446 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.07735570 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07125698 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98465582 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.98187066 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.96409020 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.96376592 |
| 52 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.90964490 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.90029270 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88650148 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.84133842 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.81049533 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80877731 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.80326035 |
| 59 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.64046540 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.63690108 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.62882165 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.61926791 |
| 63 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61237431 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.60852486 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.58228024 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57153766 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52987140 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52971464 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52346780 |
| 70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50274605 |
| 71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48971557 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47823232 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47512002 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45649440 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44727233 |
| 76 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43286281 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41812787 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41216283 |
| 79 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.40047554 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39288052 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37334288 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37167011 |
| 83 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36545384 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35598632 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.33818569 |
| 86 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31766199 |
| 87 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31487316 |
| 88 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30765806 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29824631 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25588914 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25332775 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 1.23516717 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21917106 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21046478 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20963372 |
| 96 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20932970 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20370432 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19555138 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19173922 |
| 100 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18453573 |
| 101 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.18323646 |
| 102 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17860971 |
| 103 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16678593 |
| 104 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16388584 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16097193 |
| 106 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15052436 |
| 107 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14987018 |
| 108 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14538243 |
| 109 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14253163 |
| 110 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14185571 |
| 111 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.14090029 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13061573 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.12353365 |
| 114 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11075148 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10118190 |
| 116 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08726126 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07608121 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07007132 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06926469 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06098703 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05410316 |
| 122 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.03364806 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03013458 |
| 124 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01360980 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00603492 |
| 126 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98811267 |
| 127 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98736248 |
| 128 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.97801161 |
| 129 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97299463 |
| 130 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95944777 |
| 131 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95378361 |
| 132 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94036897 |
| 133 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93358373 |
| 134 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93199648 |
| 135 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92628056 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92467023 |
| 137 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.91023841 |
| 138 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90455713 |
| 139 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90245400 |
| 140 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.89680934 |
| 141 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89550327 |
| 142 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.89463301 |
| 143 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88750380 |
| 144 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88540149 |
| 145 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.88442412 |
| 146 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88207494 |
| 147 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86286891 |
| 148 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84835710 |
| 149 | AR_19668381_ChIP-Seq_PC3_Human | 0.84682511 |
| 150 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80594095 |
| 151 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80496267 |
| 152 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79958945 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79315294 |
| 154 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.78492609 |
| 155 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77844031 |
| 156 | P68_20966046_ChIP-Seq_HELA_Human | 0.76808151 |
| 157 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.76534610 |
| 158 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.76451272 |
| 159 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.75947283 |
| 160 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.75609484 |
| 161 | MYC_22102868_ChIP-Seq_BL_Human | 0.74808998 |
| 162 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.73644505 |
| 163 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72574755 |
| 164 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72442620 |
| 165 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.71738817 |
| 166 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.71290350 |
| 167 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.71117138 |
| 168 | AR_25329375_ChIP-Seq_VCAP_Human | 0.70662105 |
| 169 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70607508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.36093387 |
| 2 | MP0003724_increased_susceptibility_to | 4.65223259 |
| 3 | MP0003880_abnormal_central_pattern | 4.19901852 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.12111345 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.37031838 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.33607785 |
| 7 | MP0002822_catalepsy | 3.25803382 |
| 8 | MP0004270_analgesia | 3.24796426 |
| 9 | MP0009745_abnormal_behavioral_response | 3.18132814 |
| 10 | MP0002419_abnormal_innate_immunity | 2.99387484 |
| 11 | MP0005025_abnormal_response_to | 2.83296829 |
| 12 | MP0002064_seizures | 2.81404267 |
| 13 | MP0001800_abnormal_humoral_immune | 2.79579263 |
| 14 | MP0005387_immune_system_phenotype | 2.78281797 |
| 15 | MP0001790_abnormal_immune_system | 2.78281797 |
| 16 | MP0005671_abnormal_response_to | 2.76116678 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.75442441 |
| 18 | MP0000685_abnormal_immune_system | 2.72686182 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.62096538 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.61023876 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.55596480 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.51778098 |
| 23 | MP0002723_abnormal_immune_serum | 2.51577011 |
| 24 | MP0001819_abnormal_immune_cell | 2.49296034 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.46725814 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.38825425 |
| 27 | MP0001486_abnormal_startle_reflex | 2.37048477 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.33008895 |
| 29 | MP0006082_CNS_inflammation | 2.32611487 |
| 30 | MP0008260_abnormal_autophagy | 2.30180208 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 2.25549415 |
| 32 | MP0002272_abnormal_nervous_system | 2.15849807 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 2.14099812 |
| 34 | MP0001533_abnormal_skeleton_physiology | 2.12542793 |
| 35 | MP0002405_respiratory_system_inflammati | 2.10753686 |
| 36 | MP0008569_lethality_at_weaning | 2.10248528 |
| 37 | MP0002398_abnormal_bone_marrow | 2.09786208 |
| 38 | MP0002132_abnormal_respiratory_system | 2.08997223 |
| 39 | MP0009046_muscle_twitch | 2.08569759 |
| 40 | MP0004858_abnormal_nervous_system | 1.99656323 |
| 41 | MP0003075_altered_response_to | 1.92894187 |
| 42 | MP0000716_abnormal_immune_system | 1.92304419 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.91670518 |
| 44 | MP0003329_amyloid_beta_deposits | 1.91483124 |
| 45 | MP0003879_abnormal_hair_cell | 1.89030956 |
| 46 | MP0004811_abnormal_neuron_physiology | 1.88289231 |
| 47 | MP0004947_skin_inflammation | 1.85110045 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.84687372 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.83837394 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 1.82235938 |
| 51 | MP0005451_abnormal_body_composition | 1.81951675 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.76550803 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.76511792 |
| 54 | MP0001970_abnormal_pain_threshold | 1.76038966 |
| 55 | MP0003866_abnormal_defecation | 1.75289969 |
| 56 | MP0002736_abnormal_nociception_after | 1.73307769 |
| 57 | MP0002722_abnormal_immune_system | 1.71288647 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.71108304 |
| 59 | MP0002909_abnormal_adrenal_gland | 1.69438091 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.69244651 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.68570020 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.68264156 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.64667286 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.62538498 |
| 65 | MP0009780_abnormal_chondrocyte_physiolo | 1.61022475 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.60917198 |
| 67 | MP0002429_abnormal_blood_cell | 1.60093416 |
| 68 | MP0003828_pulmonary_edema | 1.56861920 |
| 69 | MP0004381_abnormal_hair_follicle | 1.51623963 |
| 70 | MP0005646_abnormal_pituitary_gland | 1.49351757 |
| 71 | MP0001984_abnormal_olfaction | 1.48343200 |
| 72 | MP0005499_abnormal_olfactory_system | 1.44151506 |
| 73 | MP0005394_taste/olfaction_phenotype | 1.44151506 |
| 74 | MP0000778_abnormal_nervous_system | 1.43775528 |
| 75 | MP0000858_altered_metastatic_potential | 1.43613890 |
| 76 | MP0002067_abnormal_sensory_capabilities | 1.41997540 |
| 77 | MP0002184_abnormal_innervation | 1.41772857 |
| 78 | MP0001440_abnormal_grooming_behavior | 1.41589593 |
| 79 | MP0005409_darkened_coat_color | 1.39846909 |
| 80 | MP0008469_abnormal_protein_level | 1.37929232 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 1.37753879 |
| 82 | MP0000955_abnormal_spinal_cord | 1.35559222 |
| 83 | MP0009764_decreased_sensitivity_to | 1.33582737 |
| 84 | MP0003633_abnormal_nervous_system | 1.32962978 |
| 85 | MP0001502_abnormal_circadian_rhythm | 1.32060340 |
| 86 | MP0002882_abnormal_neuron_morphology | 1.26869087 |
| 87 | MP0008874_decreased_physiological_sensi | 1.25971670 |
| 88 | MP0003303_peritoneal_inflammation | 1.20925376 |
| 89 | MP0002653_abnormal_ependyma_morphology | 1.19834996 |
| 90 | MP0001905_abnormal_dopamine_level | 1.17011387 |
| 91 | MP0005386_behavior/neurological_phenoty | 1.15700261 |
| 92 | MP0004924_abnormal_behavior | 1.15700261 |
| 93 | MP0005083_abnormal_biliary_tract | 1.14565728 |
| 94 | MP0002998_abnormal_bone_remodeling | 1.14356166 |
| 95 | MP0001873_stomach_inflammation | 1.13649829 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 1.13319825 |
| 97 | MP0008789_abnormal_olfactory_epithelium | 1.11669673 |
| 98 | MP0004885_abnormal_endolymph | 1.11314557 |
| 99 | MP0008004_abnormal_stomach_pH | 1.08409836 |
| 100 | MP0000490_abnormal_crypts_of | 1.07754735 |
| 101 | MP0001529_abnormal_vocalization | 1.06994893 |
| 102 | MP0005058_abnormal_lysosome_morphology | 1.05751040 |
| 103 | MP0003183_abnormal_peptide_metabolism | 1.05478603 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 1.05214825 |
| 105 | MP0005166_decreased_susceptibility_to | 1.01463577 |
| 106 | MP0001663_abnormal_digestive_system | 1.00687546 |
| 107 | MP0003631_nervous_system_phenotype | 0.99959853 |
| 108 | MP0001664_abnormal_digestion | 0.97561536 |
| 109 | MP0000920_abnormal_myelination | 0.96940141 |
| 110 | MP0004808_abnormal_hematopoietic_stem | 0.94988684 |
| 111 | MP0005164_abnormal_response_to | 0.94154800 |
| 112 | MP0001188_hyperpigmentation | 0.91177853 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.89247239 |
| 114 | MP0005390_skeleton_phenotype | 0.89152138 |
| 115 | MP0002152_abnormal_brain_morphology | 0.87264744 |
| 116 | MP0000631_abnormal_neuroendocrine_gland | 0.86462698 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.86350965 |
| 118 | MP0004510_myositis | 0.86270068 |
| 119 | MP0009278_abnormal_bone_marrow | 0.85932438 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.85597404 |
| 121 | MP0005310_abnormal_salivary_gland | 0.85398920 |
| 122 | MP0003436_decreased_susceptibility_to | 0.84626674 |
| 123 | MP0009763_increased_sensitivity_to | 0.83803678 |
| 124 | MP0000343_altered_response_to | 0.83381015 |
| 125 | MP0000751_myopathy | 0.82641153 |
| 126 | MP0003448_altered_tumor_morphology | 0.80584241 |
| 127 | MP0002069_abnormal_eating/drinking_beha | 0.79813244 |
| 128 | MP0003690_abnormal_glial_cell | 0.79239606 |
| 129 | MP0003453_abnormal_keratinocyte_physiol | 0.76041603 |
| 130 | MP0006292_abnormal_olfactory_placode | 0.73212354 |
| 131 | MP0003045_fibrosis | 0.72803858 |
| 132 | MP0000015_abnormal_ear_pigmentation | 0.72305480 |
| 133 | MP0004085_abnormal_heartbeat | 0.71341937 |
| 134 | MP0002166_altered_tumor_susceptibility | 0.71188184 |
| 135 | MP0002933_joint_inflammation | 0.71111616 |
| 136 | MP0002277_abnormal_respiratory_mucosa | 0.70598384 |
| 137 | MP0003566_abnormal_cell_adhesion | 0.69133163 |
| 138 | MP0004142_abnormal_muscle_tone | 0.68936901 |
| 139 | MP0000678_abnormal_parathyroid_gland | 0.68911053 |
| 140 | MP0010234_abnormal_vibrissa_follicle | 0.68529397 |
| 141 | MP0009765_abnormal_xenobiotic_induced | 0.68057087 |
| 142 | MP0003795_abnormal_bone_structure | 0.67967436 |
| 143 | MP0004484_altered_response_of | 0.67494728 |
| 144 | MP0005377_hearing/vestibular/ear_phenot | 0.66780437 |
| 145 | MP0003878_abnormal_ear_physiology | 0.66780437 |
| 146 | MP0001177_atelectasis | 0.66419453 |
| 147 | MP0009840_abnormal_foam_cell | 0.66278745 |
| 148 | MP0008872_abnormal_physiological_respon | 0.64883873 |
| 149 | MP0001853_heart_inflammation | 0.64290347 |
| 150 | MP0003705_abnormal_hypodermis_morpholog | 0.64256325 |
| 151 | MP0000681_abnormal_thyroid_gland | 0.64161639 |
| 152 | MP0003787_abnormal_imprinting | 0.63876703 |
| 153 | MP0002138_abnormal_hepatobiliary_system | 0.62622589 |
| 154 | MP0003806_abnormal_nucleotide_metabolis | 0.62221508 |
| 155 | MP0000249_abnormal_blood_vessel | 0.61788746 |
| 156 | MP0006276_abnormal_autonomic_nervous | 0.61736651 |
| 157 | MP0000534_abnormal_ureter_morphology | 0.61292120 |
| 158 | MP0004130_abnormal_muscle_cell | 0.60586265 |
| 159 | MP0005397_hematopoietic_system_phenotyp | 0.60103978 |
| 160 | MP0001545_abnormal_hematopoietic_system | 0.60103978 |
| 161 | MP0005381_digestive/alimentary_phenotyp | 0.60085274 |
| 162 | MP0000604_amyloidosis | 0.60032798 |
| 163 | MP0005076_abnormal_cell_differentiation | 0.59575038 |
| 164 | MP0000749_muscle_degeneration | 0.58906613 |
| 165 | MP0004145_abnormal_muscle_electrophysio | 0.57865212 |
| 166 | MP0002234_abnormal_pharynx_morphology | 0.57741079 |
| 167 | MP0003137_abnormal_impulse_conducting | 0.56852967 |
| 168 | MP0003091_abnormal_cell_migration | 0.56650905 |
| 169 | MP0002332_abnormal_exercise_endurance | 0.56301985 |
| 170 | MP0002752_abnormal_somatic_nervous | 0.55543893 |
| 171 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55503617 |
| 172 | MP0002019_abnormal_tumor_incidence | 0.54913050 |
| 173 | MP0009785_altered_susceptibility_to | 0.54292936 |
| 174 | MP0005535_abnormal_body_temperature | 0.54198583 |
| 175 | MP0002089_abnormal_postnatal_growth/wei | 0.53866849 |
| 176 | MP0001851_eye_inflammation | 0.53126283 |
| 177 | MP0002229_neurodegeneration | 0.50979645 |
| 178 | MP0005464_abnormal_platelet_physiology | 0.50812231 |
| 179 | MP0004883_abnormal_blood_vessel | 0.49994681 |
| 180 | MP0001943_abnormal_respiration | 0.49443397 |
| 181 | MP0003172_abnormal_lysosome_physiology | 0.48063477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.77156982 |
| 2 | Myokymia (HP:0002411) | 6.68638191 |
| 3 | Myositis (HP:0100614) | 5.59617849 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 5.47905801 |
| 5 | Abnormality of macrophages (HP:0004311) | 5.23565352 |
| 6 | Orchitis (HP:0100796) | 5.15799515 |
| 7 | Focal seizures (HP:0007359) | 4.98229874 |
| 8 | Stomatitis (HP:0010280) | 4.92312348 |
| 9 | Visual hallucinations (HP:0002367) | 4.74633220 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.66089568 |
| 11 | Optic neuritis (HP:0100653) | 4.66089568 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56456797 |
| 13 | Febrile seizures (HP:0002373) | 4.48428126 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.45492958 |
| 15 | Epileptic encephalopathy (HP:0200134) | 4.41591257 |
| 16 | Prolonged bleeding time (HP:0003010) | 4.34859032 |
| 17 | Hypochromic anemia (HP:0001931) | 4.21568759 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 4.14999180 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.89080815 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.86377859 |
| 21 | Increased IgE level (HP:0003212) | 3.86310983 |
| 22 | Meningitis (HP:0001287) | 3.82113221 |
| 23 | Atonic seizures (HP:0010819) | 3.81343264 |
| 24 | Annular pancreas (HP:0001734) | 3.75893652 |
| 25 | Encephalitis (HP:0002383) | 3.60251785 |
| 26 | Urticaria (HP:0001025) | 3.57293857 |
| 27 | Recurrent skin infections (HP:0001581) | 3.54979601 |
| 28 | Petechiae (HP:0000967) | 3.45503795 |
| 29 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.45286656 |
| 30 | Broad-based gait (HP:0002136) | 3.43560640 |
| 31 | Keratoconjunctivitis sicca (HP:0001097) | 3.39969777 |
| 32 | Ankle clonus (HP:0011448) | 3.38451837 |
| 33 | Gingivitis (HP:0000230) | 3.36573454 |
| 34 | Microcytic anemia (HP:0001935) | 3.35361879 |
| 35 | Cellulitis (HP:0100658) | 3.33264205 |
| 36 | Papilledema (HP:0001085) | 3.31858569 |
| 37 | Vasculitis (HP:0002633) | 3.31472097 |
| 38 | Stereotypic behavior (HP:0000733) | 3.29250261 |
| 39 | Epistaxis (HP:0000421) | 3.24707533 |
| 40 | Gingival bleeding (HP:0000225) | 3.19517976 |
| 41 | Absence seizures (HP:0002121) | 3.16166295 |
| 42 | Episodic fever (HP:0001954) | 3.14566061 |
| 43 | Chest pain (HP:0100749) | 3.11666305 |
| 44 | Depression (HP:0000716) | 3.11068628 |
| 45 | Keratoconjunctivitis (HP:0001096) | 3.10296158 |
| 46 | Action tremor (HP:0002345) | 3.05220851 |
| 47 | Generalized tonic-clonic seizures (HP:0002069) | 3.03310853 |
| 48 | Recurrent cutaneous fungal infections (HP:0011370) | 3.01867975 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.01867975 |
| 50 | Poor eye contact (HP:0000817) | 2.99326734 |
| 51 | Pustule (HP:0200039) | 2.98480863 |
| 52 | Dialeptic seizures (HP:0011146) | 2.94969152 |
| 53 | Anxiety (HP:0000739) | 2.94945014 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.93095258 |
| 55 | Torticollis (HP:0000473) | 2.92896136 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.92420769 |
| 57 | Abnormal eating behavior (HP:0100738) | 2.91347746 |
| 58 | Progressive cerebellar ataxia (HP:0002073) | 2.89005773 |
| 59 | Amblyopia (HP:0000646) | 2.85478008 |
| 60 | Purpura (HP:0000979) | 2.83557739 |
| 61 | Abnormal platelet volume (HP:0011876) | 2.82174360 |
| 62 | Spinal canal stenosis (HP:0003416) | 2.80824823 |
| 63 | Obstructive sleep apnea (HP:0002870) | 2.80701536 |
| 64 | Peritonitis (HP:0002586) | 2.77815124 |
| 65 | T lymphocytopenia (HP:0005403) | 2.77580698 |
| 66 | Increased IgM level (HP:0003496) | 2.75066055 |
| 67 | Focal dystonia (HP:0004373) | 2.73488175 |
| 68 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.73430951 |
| 69 | Leukocytosis (HP:0001974) | 2.70881389 |
| 70 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.69180833 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.67250146 |
| 72 | Anorexia (HP:0002039) | 2.65439719 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.65153227 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.62542522 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.62229053 |
| 76 | Recurrent viral infections (HP:0004429) | 2.61493006 |
| 77 | Arterial thrombosis (HP:0004420) | 2.60531234 |
| 78 | Hemoptysis (HP:0002105) | 2.60487706 |
| 79 | Nonprogressive disorder (HP:0003680) | 2.56081435 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.52484011 |
| 81 | Osteomyelitis (HP:0002754) | 2.51868005 |
| 82 | Hyperventilation (HP:0002883) | 2.51173975 |
| 83 | Abnormality of T cells (HP:0002843) | 2.50976217 |
| 84 | Granulocytopenia (HP:0001913) | 2.49755062 |
| 85 | Pulmonary embolism (HP:0002204) | 2.48561103 |
| 86 | Impaired social interactions (HP:0000735) | 2.47841405 |
| 87 | Abnormal social behavior (HP:0012433) | 2.47841405 |
| 88 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.46355907 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 2.43723396 |
| 90 | Postural instability (HP:0002172) | 2.42554347 |
| 91 | Craniofacial dystonia (HP:0012179) | 2.42312189 |
| 92 | Lymphopenia (HP:0001888) | 2.42308768 |
| 93 | Slow saccadic eye movements (HP:0000514) | 2.39968877 |
| 94 | Mutism (HP:0002300) | 2.36659139 |
| 95 | Polycythemia (HP:0001901) | 2.36254181 |
| 96 | Pointed chin (HP:0000307) | 2.34155029 |
| 97 | Genetic anticipation (HP:0003743) | 2.31617388 |
| 98 | Sepsis (HP:0100806) | 2.30980554 |
| 99 | Truncal ataxia (HP:0002078) | 2.30883047 |
| 100 | Hypergammaglobulinemia (HP:0010702) | 2.27665939 |
| 101 | Amyloidosis (HP:0011034) | 2.26730980 |
| 102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.26435281 |
| 103 | Abnormal hemoglobin (HP:0011902) | 2.22784448 |
| 104 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.21931743 |
| 105 | Abnormality of T cell physiology (HP:0011840) | 2.21161793 |
| 106 | Dysmetria (HP:0001310) | 2.19508224 |
| 107 | Increased serum ferritin (HP:0003281) | 2.18540641 |
| 108 | Abnormal EKG (HP:0003115) | 2.18400913 |
| 109 | Spontaneous hematomas (HP:0007420) | 2.18375002 |
| 110 | Colitis (HP:0002583) | 2.17476817 |
| 111 | Hypoventilation (HP:0002791) | 2.15705649 |
| 112 | Sleep apnea (HP:0010535) | 2.12871661 |
| 113 | Hepatosplenomegaly (HP:0001433) | 2.12067466 |
| 114 | Abnormality of iron homeostasis (HP:0011031) | 2.12024290 |
| 115 | Eczematoid dermatitis (HP:0000976) | 2.08961426 |
| 116 | Toxemia of pregnancy (HP:0100603) | 2.07761358 |
| 117 | Megalencephaly (HP:0001355) | 2.07570258 |
| 118 | Recurrent abscess formation (HP:0002722) | 2.07379591 |
| 119 | Acne (HP:0001061) | 2.06596478 |
| 120 | Distal lower limb amyotrophy (HP:0008944) | 2.06529612 |
| 121 | Menorrhagia (HP:0000132) | 2.05451883 |
| 122 | Abnormality of the peritoneum (HP:0002585) | 2.05028436 |
| 123 | Skin ulcer (HP:0200042) | 2.04083946 |
| 124 | Progressive microcephaly (HP:0000253) | 2.03857804 |
| 125 | Abnormality of the pleura (HP:0002103) | 2.03801931 |
| 126 | Glomerulopathy (HP:0100820) | 2.03198591 |
| 127 | Impaired smooth pursuit (HP:0007772) | 2.02441711 |
| 128 | Dysmetric saccades (HP:0000641) | 2.02410093 |
| 129 | Gangrene (HP:0100758) | 2.01662885 |
| 130 | Mediastinal lymphadenopathy (HP:0100721) | 2.01488587 |
| 131 | Dysdiadochokinesis (HP:0002075) | 1.99879513 |
| 132 | Hypercortisolism (HP:0001578) | 1.98493167 |
| 133 | Abnormality of the pericardium (HP:0001697) | 1.97870463 |
| 134 | Exercise-induced myalgia (HP:0003738) | 1.97672253 |
| 135 | Primary atrial arrhythmia (HP:0001692) | 1.95902406 |
| 136 | Premature loss of primary teeth (HP:0006323) | 1.95483103 |
| 137 | Nasal polyposis (HP:0100582) | 1.94902164 |
| 138 | IgM deficiency (HP:0002850) | 1.94606817 |
| 139 | Bundle branch block (HP:0011710) | 1.93688417 |
| 140 | Apathy (HP:0000741) | 1.92888048 |
| 141 | Heterochromia iridis (HP:0001100) | 1.92111821 |
| 142 | Supraventricular tachycardia (HP:0004755) | 1.92049862 |
| 143 | Eosinophilia (HP:0001880) | 1.91610093 |
| 144 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91371725 |
| 145 | Scanning speech (HP:0002168) | 1.91365396 |
| 146 | Ventricular fibrillation (HP:0001663) | 1.91253718 |
| 147 | Agammaglobulinemia (HP:0004432) | 1.90907023 |
| 148 | Large eyes (HP:0001090) | 1.90458232 |
| 149 | Hemiplegia (HP:0002301) | 1.90136296 |
| 150 | Papilloma (HP:0012740) | 1.88407349 |
| 151 | Verrucae (HP:0200043) | 1.88407349 |
| 152 | Increased mean platelet volume (HP:0011877) | 1.88352251 |
| 153 | Insomnia (HP:0100785) | 1.87921099 |
| 154 | Metaphyseal cupping (HP:0003021) | 1.87441792 |
| 155 | Failure to thrive in infancy (HP:0001531) | 1.87334313 |
| 156 | Urinary urgency (HP:0000012) | 1.86902477 |
| 157 | Deeply set eye (HP:0000490) | 1.86423706 |
| 158 | Diminished motivation (HP:0000745) | 1.86357451 |
| 159 | Abnormality of binocular vision (HP:0011514) | 1.86027863 |
| 160 | Diplopia (HP:0000651) | 1.86027863 |
| 161 | Chronic otitis media (HP:0000389) | 1.85749984 |
| 162 | Spastic gait (HP:0002064) | 1.85738612 |
| 163 | Bradykinesia (HP:0002067) | 1.85389689 |
| 164 | Acute hepatic failure (HP:0006554) | 1.85189999 |
| 165 | Progressive inability to walk (HP:0002505) | 1.85076221 |
| 166 | Atrial fibrillation (HP:0005110) | 1.85061783 |
| 167 | Hypertensive crisis (HP:0100735) | 1.83863719 |
| 168 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83839502 |
| 169 | Fetal akinesia sequence (HP:0001989) | 1.82954399 |
| 170 | Gastrointestinal stroma tumor (HP:0100723) | 1.82919265 |
| 171 | Loss of speech (HP:0002371) | 1.82763398 |
| 172 | Viral hepatitis (HP:0006562) | 1.82529527 |
| 173 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82168695 |
| 174 | Supraventricular arrhythmia (HP:0005115) | 1.81239604 |
| 175 | Ankyloglossia (HP:0010296) | 1.80319196 |
| 176 | Vertigo (HP:0002321) | 1.80250295 |
| 177 | Iris hypopigmentation (HP:0007730) | 1.78598848 |
| 178 | Rapidly progressive (HP:0003678) | 1.77907046 |
| 179 | Agitation (HP:0000713) | 1.77665684 |
| 180 | Recurrent bacterial skin infections (HP:0005406) | 1.77283880 |
| 181 | Palpebral edema (HP:0100540) | 1.77035547 |
| 182 | Lower limb asymmetry (HP:0100559) | 1.76160582 |
| 183 | Incomplete penetrance (HP:0003829) | 1.74207877 |
| 184 | Cortical visual impairment (HP:0100704) | 1.74129621 |
| 185 | Bradycardia (HP:0001662) | 1.74012135 |
| 186 | Amyotrophic lateral sclerosis (HP:0007354) | 1.73958353 |
| 187 | Ocular albinism (HP:0001107) | 1.73513444 |
| 188 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73276872 |
| 189 | Obstructive lung disease (HP:0006536) | 1.73276872 |
| 190 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72989838 |
| 191 | Intellectual disability, severe (HP:0010864) | 1.72615235 |
| 192 | Epileptiform EEG discharges (HP:0011182) | 1.72562695 |
| 193 | Anosmia (HP:0000458) | 1.72225058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.65030730 |
| 2 | MAP4K1 | 3.67144121 |
| 3 | MAP2K3 | 3.23828184 |
| 4 | MAP3K9 | 3.23774744 |
| 5 | NTRK3 | 3.17602355 |
| 6 | MAP3K12 | 2.73224386 |
| 7 | DAPK2 | 2.68835241 |
| 8 | RIPK4 | 2.49672643 |
| 9 | TYK2 | 2.47338200 |
| 10 | PRPF4B | 2.39433237 |
| 11 | EPHB1 | 2.31555194 |
| 12 | MAP3K3 | 2.19551809 |
| 13 | KSR2 | 2.16142294 |
| 14 | MINK1 | 2.09222350 |
| 15 | TAOK1 | 2.06144479 |
| 16 | ZAP70 | 2.03924357 |
| 17 | MAP2K7 | 2.00839651 |
| 18 | CDK19 | 1.84201506 |
| 19 | DAPK1 | 1.83152252 |
| 20 | KSR1 | 1.72233024 |
| 21 | NTRK2 | 1.72004409 |
| 22 | JAK3 | 1.67116587 |
| 23 | TNIK | 1.65317286 |
| 24 | MARK1 | 1.64351671 |
| 25 | PAK6 | 1.59087754 |
| 26 | ARAF | 1.57383942 |
| 27 | CAMKK1 | 1.53685054 |
| 28 | FES | 1.53020895 |
| 29 | SIK3 | 1.51951464 |
| 30 | MAP3K13 | 1.49794839 |
| 31 | TXK | 1.47164144 |
| 32 | PRKD3 | 1.45880745 |
| 33 | CASK | 1.39502888 |
| 34 | SIK2 | 1.37612108 |
| 35 | MAPK13 | 1.37369023 |
| 36 | UHMK1 | 1.33032612 |
| 37 | TBK1 | 1.31867946 |
| 38 | CDK5 | 1.30355858 |
| 39 | SMG1 | 1.30033420 |
| 40 | ERBB3 | 1.23571659 |
| 41 | JAK2 | 1.22141325 |
| 42 | LYN | 1.21616130 |
| 43 | TRIB3 | 1.19983751 |
| 44 | MAP3K14 | 1.19672557 |
| 45 | CAMK1 | 1.17902195 |
| 46 | MAP3K4 | 1.17760141 |
| 47 | RAF1 | 1.16514461 |
| 48 | FGR | 1.16021736 |
| 49 | RIPK1 | 1.15951889 |
| 50 | MAP2K6 | 1.14889822 |
| 51 | MAP3K1 | 1.14074115 |
| 52 | MARK3 | 1.12630720 |
| 53 | PTK6 | 1.11515189 |
| 54 | SGK2 | 1.10333383 |
| 55 | LCK | 1.07964582 |
| 56 | NTRK1 | 1.06876815 |
| 57 | SGK494 | 1.06527465 |
| 58 | SGK223 | 1.06527465 |
| 59 | MAP2K4 | 1.05998883 |
| 60 | SIK1 | 1.05751046 |
| 61 | DMPK | 1.04397677 |
| 62 | JAK1 | 1.03248350 |
| 63 | SGK3 | 1.03200803 |
| 64 | YES1 | 1.00414399 |
| 65 | TAOK3 | 0.98910438 |
| 66 | TESK2 | 0.97515765 |
| 67 | ITK | 0.96226390 |
| 68 | CSF1R | 0.90652639 |
| 69 | GRK5 | 0.90411790 |
| 70 | BMPR2 | 0.88175523 |
| 71 | MAP3K7 | 0.87640500 |
| 72 | MARK2 | 0.86701778 |
| 73 | IKBKB | 0.82280189 |
| 74 | STK10 | 0.82076315 |
| 75 | IRAK1 | 0.82002244 |
| 76 | CAMKK2 | 0.81733410 |
| 77 | MUSK | 0.80631083 |
| 78 | CAMK4 | 0.77868697 |
| 79 | IRAK2 | 0.77702453 |
| 80 | EPHA3 | 0.77180994 |
| 81 | ERN1 | 0.76623999 |
| 82 | PTK2B | 0.76551994 |
| 83 | LRRK2 | 0.75861200 |
| 84 | BMX | 0.74995867 |
| 85 | STK38 | 0.74756972 |
| 86 | FGFR4 | 0.74498130 |
| 87 | PRKD2 | 0.74149482 |
| 88 | PRKCH | 0.73073252 |
| 89 | PINK1 | 0.72645582 |
| 90 | CDK18 | 0.69264051 |
| 91 | CDK14 | 0.68668466 |
| 92 | CAMK2A | 0.66810433 |
| 93 | MAP3K2 | 0.66708973 |
| 94 | IRAK4 | 0.66486681 |
| 95 | DYRK1B | 0.65378939 |
| 96 | KIT | 0.64559301 |
| 97 | CDK15 | 0.63142609 |
| 98 | FYN | 0.62934796 |
| 99 | MAP3K6 | 0.62811629 |
| 100 | PDK1 | 0.62754103 |
| 101 | CDC42BPA | 0.62663253 |
| 102 | PLK2 | 0.62534946 |
| 103 | CDK11A | 0.62083296 |
| 104 | TEC | 0.61933742 |
| 105 | STK11 | 0.61072922 |
| 106 | PHKG1 | 0.60681255 |
| 107 | PHKG2 | 0.60681255 |
| 108 | HCK | 0.60326250 |
| 109 | PRKCG | 0.58469377 |
| 110 | PIM1 | 0.57595737 |
| 111 | TNK2 | 0.57122097 |
| 112 | TAOK2 | 0.57097765 |
| 113 | MAP3K10 | 0.56405650 |
| 114 | PDPK1 | 0.56097329 |
| 115 | SGK1 | 0.56024766 |
| 116 | SYK | 0.55478869 |
| 117 | TYRO3 | 0.55002210 |
| 118 | BLK | 0.54395877 |
| 119 | MAP3K5 | 0.54321290 |
| 120 | NLK | 0.52241180 |
| 121 | GRK6 | 0.52207212 |
| 122 | HIPK2 | 0.51134761 |
| 123 | DAPK3 | 0.50007188 |
| 124 | RPS6KC1 | 0.49691728 |
| 125 | RPS6KL1 | 0.49691728 |
| 126 | BTK | 0.48970643 |
| 127 | RET | 0.48841848 |
| 128 | MOS | 0.48481025 |
| 129 | FGFR3 | 0.47379074 |
| 130 | MAP3K8 | 0.45958394 |
| 131 | PRKCQ | 0.45897398 |
| 132 | MAPK12 | 0.45753620 |
| 133 | MAPK7 | 0.45678346 |
| 134 | MATK | 0.45649831 |
| 135 | CAMK2B | 0.45601630 |
| 136 | PTK2 | 0.43962703 |
| 137 | CLK1 | 0.43070261 |
| 138 | TGFBR2 | 0.42525870 |
| 139 | PRKG2 | 0.42355391 |
| 140 | ICK | 0.42258123 |
| 141 | RPS6KA2 | 0.42043116 |
| 142 | MAPKAPK2 | 0.41792490 |
| 143 | CDK12 | 0.41773282 |
| 144 | PRKCZ | 0.40573601 |
| 145 | DYRK1A | 0.39934059 |
| 146 | RPS6KA6 | 0.39009176 |
| 147 | MAP3K11 | 0.38861180 |
| 148 | PKN2 | 0.38018110 |
| 149 | CSK | 0.37830307 |
| 150 | IRAK3 | 0.35251530 |
| 151 | IKBKE | 0.34348939 |
| 152 | ALK | 0.28721149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.98007639 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.61245614 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.54640684 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50518646 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41766164 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.28818568 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.22494288 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.20854302 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.17386370 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16977357 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08046570 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.07088072 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.06151307 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.04657921 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02585372 |
| 16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.97294561 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.96432769 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94016191 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.93026285 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.91557201 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.89165500 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76391417 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76155708 |
| 24 | Measles_Homo sapiens_hsa05162 | 1.75349911 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74287489 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70240810 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65448692 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62295686 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61626522 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61365755 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.58326739 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.57667854 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.56741283 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.56016003 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53563232 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50747480 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.49792545 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46195437 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45920853 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45840667 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.43007988 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.41953597 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.40996459 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.39359102 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39280204 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37559350 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36594839 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.35385305 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34819865 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28002726 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26226533 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.22933039 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22603190 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.22442975 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 1.22438993 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 1.21192381 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 1.20663558 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20552161 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 1.19652870 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18381146 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 1.17641554 |
| 62 | Gap junction_Homo sapiens_hsa04540 | 1.17613206 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15937971 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12674553 |
| 65 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11634365 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.11362496 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04533772 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 1.01188105 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00760422 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00266927 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99432475 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99138762 |
| 73 | Melanogenesis_Homo sapiens_hsa04916 | 0.98013055 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97282693 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96085429 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96034452 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94401172 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.93460312 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86904877 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86103389 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83027056 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82741886 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.81718742 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81431513 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81274832 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.81079295 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80819038 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.79527104 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79525713 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.79342812 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78902081 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.77853572 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.77633103 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77209100 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77000790 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76915102 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76724237 |
| 98 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76366910 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76278187 |
| 100 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.76195109 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75271794 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74741762 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74386095 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74345166 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.74211097 |
| 106 | Asthma_Homo sapiens_hsa05310 | 0.74195737 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70616715 |
| 108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69309730 |
| 109 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68666379 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68474275 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67996540 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66572513 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.66343009 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.66236580 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65827885 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64997004 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64085215 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63587550 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63250662 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63199194 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62685948 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62030561 |
| 123 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61744273 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61727151 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60965112 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.60601664 |
| 127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60047111 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59625523 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59365263 |
| 130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59109107 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58838396 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58803412 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58084489 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.56812660 |
| 135 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55753950 |
| 136 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55621347 |
| 137 | Lysosome_Homo sapiens_hsa04142 | 0.55477686 |
| 138 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53702856 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53312659 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.53217986 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52392862 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52035676 |
| 143 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51977105 |
| 144 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48924533 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48360841 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48198290 |
| 147 | Prostate cancer_Homo sapiens_hsa05215 | 0.47342160 |
| 148 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46779398 |
| 149 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46729770 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46696872 |
| 151 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44110865 |
| 152 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.43821128 |
| 153 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.43176676 |
| 154 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43020773 |

